Tvardi Therapeutics Inc (TVRD)

$17.04 -1.21 (-6.63%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -17.35M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 38,200
Avg Vol 7,972
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 39%
Beta N/A
Analysts Strong Sell
Price Target $288.14

Latest News on TVRD

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Apr 15, 2025, 4:05 PM EDT - 4 days ago

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

CARA